2015 American Transplant Congress

Tuesday, May 5, 2015

3:03pm-3:15pm

Effect of Everolimus on Left Ventricular Hypertrophy in De Novo Kidney Transplant Recipients: 12-Month Results from the ELEVATE Study

M. van der Giet,¹ H. Holdaas,¹ J. de Fijter,¹ A. Speziale,² C. Escrig,² G. Junge,² Z. Wang,³ J. Cruzado.¹

Concurrent Session: Kidney: Cardiovascular and Metabolic  •  Terrace I-III

3:03pm-3:15pm

Everolimus Initiation Immediately After Liver Transplantation: A Single-Center Experience

U. Herden, A. Galante, S. Pischke, L. Fischer, J. Li, M. Koch, E. Achilles, B. Nashan, M. Sterneck.

Concurrent Session: Liver: Immunosuppression and Rejection  •  Room 120-ABC

3:03pm-3:15pm

Improved Long-Term Graft Survival in Renal Transplant Recipients With Donor Specific Antibodies (DSA) After Mycophenolic Acid Escalation

L. Rebellato,¹ K. Parker,² F. Rana,³ S. Kendrick,⁴ C. Morgan,⁵ C. Haisch,⁵ M. Everly,⁶ R. Harland,⁵ P. Bolin.³

Concurrent Session: Kidney: Antibodies and Allograft Injury  •  Room 118-AB

3:03pm-3:15pm

Interim Results of a Phase 1 Trial of Treg Adoptive Cell Transfer (TRACT) in Living Donor Kidney Transplant Recipients

J. Leventhal,¹ A. LeFever,² A. Skaro,¹ L. Gallon,¹ J. Mathew,¹ D. Stare,¹ I. Konieczna,¹ J. He,¹ G. Johnson.³

Concurrent Session: Late Breaking  •  Terrace IV

3:03pm-3:15pm

Kidney Plasmacytoid Dendritic Cells Display Distinct Cell Surface Markers and May Explain the Induction of Tolerance by Kidney Allografts

N. Oh, M. Tonsho, D. Ndishabandi, R. Colvin, J. Madsen, A. Alessandrini.

Concurrent Session: Transplant Tolerance: Animal Models II  •  Room 118-C

3:03pm-3:15pm

Living Donor Liver Transplantation for Biliary Atresia has Equivalent Survival and Shorter Waiting Time Compared to Deceased Donor Liver Transplantation

S. Alexopoulos,¹ V. Nekrasov,¹ L. Matsuoka,¹ K. Chouliaras,² Y. Genyk.¹

Concurrent Session: Liver: Living Donors and Partial Grafts  •  Room 115-AB

3:03pm-3:15pm

Post-Transplant Lymphoproliferative Disorders Following Alemtuzumab Induction in Kidney Transplantation

H. Sawhney, R. Charif, J. Galliford, A. Mclean, D. Taube.

Concurrent Session: PTLD and Other Malignancies  •  Room 122-AB

3:03pm-3:15pm

Surgical Site Infections After Intestinal and Multivisceral Transplantation

K. Etesami, R. Girlanda, J. Steele, Y. Kwon, J. Hawksworth, C. Desai, E. Island, C. Matsumoto, T. Fishbein.

Concurrent Session: Small Bowel Transplantation  •  Room 117

3:15pm-3:27pm

1-Year Safety and Efficacy of Eculizumab in Adult aHUS Patients, With or Without a History of Renal Transplant

C. Legendre,¹ J. Kincaid,² C. Bedrosian,² C. Loirat.³

Concurrent Session: Glomerulonephritis/Recurrent Disease  •  Room 121-AB

3:15pm-3:27pm

A Prospective and Randomized Study of Conversion from Tacrolimus to Cyclosporine A to Improve Glucose Metabolism in Patients With New-Onset Diabetes Mellitus After Renal Transplantation

K. Wissing,¹ D. Abramowicz,² L. Weekers,³ K. Budde,⁴ T. Rath,⁵ O. Witzke,⁶ D. Kuypers.⁷

Concurrent Session: Kidney: Cardiovascular and Metabolic  •  Terrace I-III